<DOC>
	<DOCNO>NCT01539122</DOCNO>
	<brief_summary>The objective randomized control study obtain outcome data Zimmer TM glenoid component analysis standard score system radiographs comparison cement glenoid component . In addition , investigator plan provide cost analysis base economic data collect justify cost difference implant . Patients acceptable glenoid bone stock randomize two group treat either TM Glenoid cement glenoid component minimum 2 year follow-up ; maximum 10 year follow-up . Hypothesis : The early long-term clinical outcome radiographic analysis TM glenoid component superior cement glenoid component total shoulder arthroplasty patient .</brief_summary>
	<brief_title>Clinical Experience With Zimmer Trabecular Metal ( TM ) Glenoid Total Shoulder Arthroplasty</brief_title>
	<detailed_description>Total shoulder arthroplasty successful relieve pain restore function joint , chronic loosening glenoid implant remain common complication . The Zimmer Trabecular Metal ( TM ) Glenoid monoblock implant reconstructive total shoulder arthroplasty . To date , publish clinical data available confirm evidence effectiveness specific product . The purpose prospective study obtain short long-term clinical outcome data Zimmer TM Glenoid analysis standard score system radiographic analysis . The TM Glenoid Component intend function within Zimmer , Inc. 's Bigliani/Flatow ( B/F ) Complete Shoulder Solution . The device monoblock glenoid component comprise Trabecular Metal base , design interface articulate Zimmer , Inc. 's B/F humeral component . The Trabecular Metal Glenoid design articular surface manufacture ultra-high molecular weight polyethylene ( UHMWPE ) . The base implant cruciate TM keel provide stability initial fixation use press-fit implant bone . Long-term fixation provide biological ingrowth TM material . Surgical fixation trabecular metal device obtain via press-fit . Surgical fixation comparison all-polyethylene glenoid component Palacos/CoPal bone cement This multi-centre , randomize control study evaluate clinical radiological performance TM Glenoid series patient adequate glenoid bone stock receive total shoulder replacement . The comparison group consecutive series randomize patient implant cemented all-polyethylene glenoid component . This study descriptive nature seek demonstrate superiority ( non-inferiority ) TM Glenoid cement all-polyethylene glenoid component .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Age 18 year minimum 80 year age maximum . Gender male female . Primary Diagnosis : Primary Glenohumeral Osteoarthritis Informed Consent patient sign 'Patient Informed Consent form ' Surgery date : Beginning January 1 , 2012 KEY The critical inclusion criterion patient selection TM Cemented glenoid prosthesis base adequacy glenoid bone stock/quality time implantation . Preoperative CT scan intraoperative decision surgeon time surgery determine issue bone stock/quality . Age &gt; 80 year Significant Bone Loss ( classify concentric v eccentric ; contain v uncontained ) preoperative CT scan requiring cement prosthesis . Evidence major joint trauma , infection , avascular necrosis , cuff tear arthropathy , inflammatory arthropathy , chronic dislocation , massive rotator cuff tear previous shoulder surgery ( arthroscopic debridement ) Preoperative compute tomography scan shoulder show insufficient glenoid bone stock allow implantation glenoid prosthesis Active joint systematic infection , significant muscle paralysis , Charcot arthropathy Life expectancy le 2 year unacceptably high operative risk Inability speak read English Psychiatric illness cognitive deficit preclude informed consent Unwillingness follow 5 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>osteoarthritis</keyword>
	<keyword>shoulder replacement</keyword>
</DOC>